vimarsana.com
Home
Live Updates
New Preclinical Data on AI-Generated Target Identified in Be
New Preclinical Data on AI-Generated Target Identified in Be
New Preclinical Data on AI-Generated Target Identified in BenevolentAI and AstraZeneca Collaboration Presented at ATS 2023
Research, presented by AstraZeneca, provides information on the biological validation of Serum Response Factor as a potential target for idiopathic pulmonary fibrosis The target was discovered
Related Keywords
London ,
City Of ,
United Kingdom ,
New York ,
United States ,
Rajin Kang ,
Astrazeneca ,
International Conference ,
Vp Communications ,
Serum Response Factor ,
Benevolent Platform ,
Euronext Amsterdam ,
Artificial Intelligence ,
Central Profibrotic Mechanism ,
Idiopathic Pulmonary Fibrosis ,
Gefallene Big Techs ,
Preclinical ,
Data ,
Enerated ,
Target ,
Dentified ,
Benevolentai ,
Collaboration ,
Resented ,
023 ,